Dutasteride

度他雄胺

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameDutasteride
Drug Alias Name度他甾胺DutasteridumDutasteridaZagalloAvodart +[14] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionSteroid 5 alpha reductase inhibitors
TargetsSteroid 5 alpha reductase
Therapy Area/IndicationsDepressionAlcoholismPremenstrual Syndrome +[11] 
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaProstatic Hyperplasia
Original Approved Country/TerritoryUnited States
Original Approved Date2001/11/20
Country/TerritoryBelgiumBulgariaCanada +[52] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesCentre de recherche du CHU de Québec-Université LavalBio-innova Co LtdWaylis Therapeutics LLC +[7] 
Inactive CompaniesStiefel LaboratoriesRoswell Park Cancer InstituteSidney Kimmel Cancer Center At Thomas Jefferson University +[14] 
Active IndicationsAlcoholismAlopeciaUrinary Retention +[5] 
Inactive IndicationsDepressionPremenstrual SyndromeDysmenorrhea +[6] 

Other Information

ATC CodeG04CB02
Related LinksWikipediaDrugBankKEGG